SAMR issues guidance for registration of foods for special medical purposes
China
Jan 23, 2025
The State Administration for Market Regulation (SAMR) issued new guidance regarding the registration of nutritionally complete food for special medical purposes. For the development of the guideline, formula development, production practices, clinical applications and registration practices of complete nutritional formula foods for special medical purposes were considered in order to optimize the requirements of product registration application materials and on-site verification in accordance with the “Regulations on the Registration and Administration of Formula Foods for Special Medical Purposes”.
For further information (in Chinese), click on the Link
Tags:
China prioritizes review of 4 foods for special medical purposes
China
Jul 05, 2024
Therapeutic Products Act to be repealed
New Zealand
May 27, 2024
New Draft Standard on Nutritionally Complete Food for Cancer Patients
China
Oct 30, 2023
EU - Food or Medicine? A European Regulatory Perspective on Nutritional Therapy Products to treat Inborn Errors of Metabolism
European Union
Sep 11, 2023
ANMAT updates procedural fees for foods, supplements and FSMP
Argentina
Jul 10, 2023
SAMR to revise advertising rules for Drugs, Medical Devices, Health Food and FSMP
China
Jun 02, 2023
Guidance About Medical Foods published
USA
Mar 16, 2023
New Codex Guidelines for ready-to-use therapeutic foods published
Codex
Mar 13, 2023
Regulation on food for special medical purposes
China
Dec 14, 2022
Food for special medical purposes
Taiwan
Nov 24, 2022
EU - CJEU: Definition of medical foods should be interpreted strictly
European Union
Nov 07, 2022
EU/ UK/ US/ China - Foods for special medical purposes/medical foods: A global regulatory synopsis
European Union
Sep 08, 2022
Medical foods in USA at a glance
USA
Feb 14, 2022
Food-Medicine Interface and its Application in International Level, Comparative Jurisdictions and Sri Lankan Legal Context
Sri Lanka
May 03, 2021
EFSA:Response to comments on the Scientific Opinion of the EFSA Panel on Nutrition, Novel Foods and Food Allergens (NDA) on the scientific substantiation of a health claim related to Bifidobacterium animalis subsp. lactis Biâ07 contributes to increasing lactose digestion pursuant to Article 13.5 of Regulation (EC) No 1924/2006
Feb 03, 2021
Expertise in countries
- Argentina
- Australia
- Brazil
- Brunei
- Cambodia
- Canada
- Chile
- Colombia
- Ecuador
- Egypt
- European Union
- India
- Indonesia
- Laos
- Japan
- Malaysia
- Mexico
- Myanmar
- New Zealand
- Nigeria
- Paraguay
- Philippines
- Peru
- Russia
- Saudi Arabia
- Singapore
- South Africa
- South Korea
- Switzerland
- Thailand
- Turkey
- UAE
- UK
- Ukraine
- Uruguay
- USA
- Vietnam
